Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis

Eva M Strijbis; Eline Coerver; Jop Mostert; Zoé L E van Kempen; Joep Killestein; Jacynthe Comtois; Pavle Repovic; James D Bowen; Gary Cutter; Marcus Koch

doi:10.1136/jnnp-2022-330887

Article info

Multiple sclerosis

Original research

Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis

Authors

Eva M Strijbis Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands PubMed articles Google scholar articles
Eline Coerver Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands PubMed articles Google scholar articles
Jop Mostert Department of Neurology, Rijnstate Hospital Arnhem, Arnhem, The Netherlands PubMed articles Google scholar articles
Zoé L E van Kempen Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands PubMed articles Google scholar articles
Joep Killestein Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands PubMed articles Google scholar articles
Jacynthe Comtois Department of Medicine, Neurology service, Maisonneuve-Rosemont Hospital, Montreal, Québec, Canada PubMed articles Google scholar articles
Pavle Repovic Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, Washington, USA PubMed articles Google scholar articles
James D Bowen Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, Washington, USA PubMed articles Google scholar articles
Gary Cutter Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama, USA PubMed articles Google scholar articles
Marcus Koch Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada PubMed articles Google scholar articles

Correspondence to Eva M Strijbis, Neurology, Amsterdam UMC-Locatie VUMC, 1081 HV, Amsterdam, The Netherlands; e.strijbis{at}amsterdamumc.nl

View Full Text

Citation

Strijbis EM, Coerver E, Mostert J, et al

Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis

Journal of Neurology, Neurosurgery & Psychiatry 2023;94:792-799.

Publication history

Received December 9, 2022
Accepted April 18, 2023
First published May 12, 2023.

Online issue publication

October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password